The challenge of Adenomyosis across the ART journey: insights from the Naples Workshop group
Review
OA: hybrid
public-domain-us
Abstract
Adenomyosis is increasingly recognized in women of reproductive age and may adversely affect fertility, assisted reproductive technology (ART) outcomes, and pregnancy. However, its optimal management in women seeking pregnancy remains uncertain, with substantial heterogeneity in diagnostic criteria, disease phenotypes, and available therapeutic evidence. This narrative review, informed by the multidisciplinary discussion of the Naples Workshop on Adenomyosis and ART (10th-12th October 2025), critically examines the available evidence on adenomyosis throughout the ART journey. Available evidence is critically synthesized, with multidisciplinary clinical perspectives incorporated where appropriate, to identify practical clinical considerations, areas of uncertainty, and priorities for future research. The review is structured into three sections according to the phase of adenomyosis management during the ART timeline: (i) before ART, including diagnosis, ovarian reserve assessment and potential pre-treatment; (ii) during ART, including embryo transfer strategies; (iii) after ART, addressing pregnancy-related risks, antenatal surveillance, delivery, and postpartum management. This expert narrative review integrates available evidence with multidisciplinary clinical expertise to provide practical considerations for patient management while identifying areas of uncertainty and priorities for future research. Overall, management should be individualized according to disease phenotype, symptoms, reproductive potential, previous ART history, and coexisting conditions, while several commonly proposed interventions still require confirmation in well-designed prospective studies.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- europepmc
- last seen: 2026-11-18T06:10:28.346261+00:00
- openalex
- last seen: 2026-11-18T06:02:33.299327+00:00
- pubmed
- last seen: 2026-11-18T06:04:25.516603+00:00
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine
Courtesy of the U.S. National Library of Medicine